Table 2.
Comparison of parameters 6 mo later
| Variables | Controlled | PUFA | P value |
| n | 39 | 39 | |
| BMI (kg/m2) | 26.4 ± 1.0 | 25.8 ± 1.2 | 0.065 |
| Smoking, n (%) | 15 (38.5) | 14 (35.9) | 0.278 |
| ALT (U/L) | 80.4 ± 7.6 | 67.8 ± 5.3 | < 0.01 |
| AST (U/L) | 75.6 ± 5.8 | 60.3 ± 6.8 | < 0.01 |
| Bilirubin, total (md/dL) | 0.8 ± 0.2 | 0.7 ± 0.2 | 0.343 |
| Bilirubin, direct (md/dL) | 0.6 ± 0.1 | 0.6 ± 0.2 | 0.338 |
| FBG (mmol/L) | 5.9 ± 0.2 | 5.9 ± 0.3 | 0.285 |
| TG (mmol/L) | 2.4 ± 0.4 | 1.8 ± 0.3 | 0.015 |
| TC (mmol/L) | 5.2 ± 0.6 | 4.7 ± 0.3 | 0.040 |
| LDL-C (mmol/L) | 3.5 ± 0.5 | 3.1 ± 0.6 | 0.062 |
| HDL-C (mmol/L) | 1.1 ± 0.3 | 1.3 ± 0.4 | 0.105 |
| CRP (mg/L) | 9.2 ± 0.8 | 7.6 ± 0.4 | 0.045 |
| MDA (nmol/mL) | 0.6 ± 0.1 | 0.4 ± 0.2 | 0.048 |
| Type IV collagen (ng/mL) | 4.6 ± 0.7 | 3.5 ± 0.5 | 0.023 |
| P-III-P (U/mL) | 0.8 ± 0.2 | 0.5 ± 0.3 | 0.039 |
| Weekly exercise time (min) | 107.6 ± 12.3 | 109.5 ± 10.4 | 0.272 |
ALT: Alanine aminotransferase; AST: Aspartase aminotransferase; BMI: Body mass index; PUFA: Poly-unsaturated fatty acid; MDA: Malondialdehyde; LDL-C: Lipoprotein-cholesterol; HDL-C: High-density lipoprotein-cholesterol; CRP: C-reactive protein; FBG: Fasting blood glucose; TG: Triglyceride; TC: Total cholesterol.